However, the pathogenesis of AD cannot be fully explained by the aggregation of Aβ and tau proteins alone, and strategies to reduce the burden of Aβ have not been effective in limiting disease progression (Morris et al. 2014). The gene discussed is MAPT; the disease is Alzheimer disease.